Tsakaldimis, G.; Diamantidis, D.; Lailisidis, S.; Kafalis, C.; Panagiotopoulos, N.; Georgellis, C.; Giannopoulos, S.; Chousein, C.; Spounos, M.; Deligeorgiou, E.;
et al. Evaluating the Diagnostic Role of the Testosterone-to-Prostate-Specific Antigen Ratio in Pre-Biopsy Risk Stratification of Prostate Cancer. J. Clin. Med. 2025, 14, 3022.
https://doi.org/10.3390/jcm14093022
AMA Style
Tsakaldimis G, Diamantidis D, Lailisidis S, Kafalis C, Panagiotopoulos N, Georgellis C, Giannopoulos S, Chousein C, Spounos M, Deligeorgiou E,
et al. Evaluating the Diagnostic Role of the Testosterone-to-Prostate-Specific Antigen Ratio in Pre-Biopsy Risk Stratification of Prostate Cancer. Journal of Clinical Medicine. 2025; 14(9):3022.
https://doi.org/10.3390/jcm14093022
Chicago/Turabian Style
Tsakaldimis, Georgios, Dimitrios Diamantidis, Stavros Lailisidis, Charalampos Kafalis, Nikolaos Panagiotopoulos, Chrysostomos Georgellis, Stavros Giannopoulos, Chousein Chousein, Marios Spounos, Evangelia Deligeorgiou,
and et al. 2025. "Evaluating the Diagnostic Role of the Testosterone-to-Prostate-Specific Antigen Ratio in Pre-Biopsy Risk Stratification of Prostate Cancer" Journal of Clinical Medicine 14, no. 9: 3022.
https://doi.org/10.3390/jcm14093022
APA Style
Tsakaldimis, G., Diamantidis, D., Lailisidis, S., Kafalis, C., Panagiotopoulos, N., Georgellis, C., Giannopoulos, S., Chousein, C., Spounos, M., Deligeorgiou, E., Giannakopoulos, S., & Kalaitzis, C.
(2025). Evaluating the Diagnostic Role of the Testosterone-to-Prostate-Specific Antigen Ratio in Pre-Biopsy Risk Stratification of Prostate Cancer. Journal of Clinical Medicine, 14(9), 3022.
https://doi.org/10.3390/jcm14093022
